New study probes emotional impact of Cutting-Edge prostate cancer scans

NCT ID NCT06523777

Ongoing Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how a new, more sensitive type of PET scan (PSMA PET) affects the anxiety, decision-making, and quality of life of 350 men with prostate cancer. Participants will fill out surveys about their feelings and experiences over a year. The goal is to understand the real-world impact of this advanced imaging technology.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Griffin Hospital

Derby, Connecticut, 06418, United States
Radiology and Biomedical Imaging - New Haven - Smilow Cancer Hospital (North Pavilion):

New Haven, Connecticut, 06520, United States
Saint Raphael's Radiology and Biomedical Imaging, Basement Location.

New Haven, Connecticut, 06520, United States
Yale New Haven Health Bridgeport Hospital - Park Ave Medical Center

Bridgeport, Connecticut, 06611, United States
Yale New Haven Health Greenwich Hospital

Greenwich, Connecticut, 06830, United States
Yale New Haven Health Lawrence & Memorial Hospital

New London, Connecticut, 06320, United States
Yale New Haven Health Westerly Hospital

Westerly, Rhode Island, 02891, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.